
Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. At Evolus, you have the opportunity to be part of a movement. A performance beauty company changing the game. We are bringing innovation and forward-thinking technology to an industry desperately wanting frictionless experiences. Our work disrupts the status quo, but most importantly, we will make an impact, we are customer-centric - always. Because of this, we are excited to step through the door each morning. We help each other climb; we don't climb over one another. We believe that integrity and a team-driven environment connect entrepreneurial minds. Getting goose bumps? Good. Join the Evolus movement, and let's see where you can put your talents to work.
Unlock the market timeline & signal feed
7 signals in the last 90 days.
The order this company entered each market — oldest to newest
Medical Affairs Clinician - Italy
Telix Appoints David Gill as Director
Sign up to see the full signal feed
How Evolus's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
EvolusYou | 7 | 5 | -83% | 7 | 23 |
Professional Education Manager INTL
View postingMilan, Lombardy, Italy · 5d ago
International Marketing Specialist
View postingMilan, Lombardy, Italy · 5d ago
Aesthetic Experience Manager – Hawaii
View postingHonolulu, HI · 3w ago
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Telix Pharmaceuticals appoints David Gill as Non-Executive Director effective May 11, 2026, with plans for him to become Chair. Gill brings 35+ years of life sciences experience.
Telix Pharmaceuticals appoints David Gill as Non-Executive Director effective May 11, 2026, as part of board expansion. Gill will eventually succeed Dr. Mark Nelson as Chair.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Evolus's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.